Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o
article
Author/s
author: Jean-Jacques Grob, Daniil Stroyakovskiy, Kamil Drucis, Vanna Chiarion Sileni, Piotr Rutkowski, Evgeny V Levchenko, Georgina V. Long, Andrzej Mackiewicz, Antoni Ribas, Keith Flaherty, Jacob Schachter, Reinhard Dummer, Dirk Schadendorf, Boguslawa Karaszewska, Jeffrey J Legos, Bijoyesh Mookerjee, Mayur M Amonkar, Diane Opatt McDowell, Axel Hauschild
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.